Clinical Trials List
Protocol NumberB7461039
Active
2022-03-01 - 2026-12-31
Phase IV
Recruiting1
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
200 participants
